Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07570355
What this trial is testing

Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Shanghai Institute of Acupuncture, Moxibustion and Meridian 62
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Large-scale testing (Phase 3)Study completedNCT04435366
What this trial is testing

Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Who this might be right for
Geographic AtrophyMacular Degeneration
IVERIC bio, Inc. 448
Not applicableEnded earlyNCT02399072
What this trial is testing

Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 202
Early research (Phase 1)Study completedNCT04744662
What this trial is testing

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
ONL Therapeutics 28
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Not applicableStudy completedNCT06381596
What this trial is testing

Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
University of Wisconsin, Madison 32
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Looking for participantsNCT07215234
What this trial is testing

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Sanofi 104
Early research (Phase 1)WithdrawnNCT01093170
What this trial is testing

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Mark Kleinman
Large-scale testing (Phase 3)Looking for participantsNCT06541704
What this trial is testing

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Who this might be right for
Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)
Regeneron Pharmaceuticals 975
Not applicableLooking for participantsNCT01866371
What this trial is testing

High Resolution Retinal Imaging

Who this might be right for
StargardtsRetinitis PigmentosaAge-related Macular Degeneration+2 more
University of Pennsylvania 600
Not applicableWithdrawnNCT05941273
What this trial is testing

The SING IMT in an Israeli Cohort

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
VisionCare, Inc.
Post-approval studies (Phase 4)Active Not RecruitingNCT06970665
What this trial is testing

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc 17
Testing effectiveness (Phase 2)Study completedNCT02288559
What this trial is testing

Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Genentech, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT00429936
What this trial is testing

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Sirion Therapeutics, Inc. 245
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more
Perceive Biotherapeutics, Inc. 60
Not applicableStudy completedNCT03451578
What this trial is testing

Alpha MSH in Ocular Disease

Who this might be right for
Advanced Dry Macular Degeneration
Duke University 54
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Next Page